Literature DB >> 16609071

Natural history of cerebral vein thrombosis: a systematic review.

Francesco Dentali1, Monica Gianni, Mark A Crowther, Walter Ageno.   

Abstract

UNLABELLED: Cerebral vein thrombosis (CVT) has been considered, until a few years ago, an uncommon disease with significant long-term morbidity and high mortality rate. New noninvasive diagnostic techniques have increased the frequency with which this disease is diagnosed; despite this, there continues to be little data on its natural history. The objectives of this study were to evaluate the mortality rate, the rate of disability at long-term follow-up, and the incidence of recurrence after a first episode of CVT; to determine clinical and radiologic predictors of death and dependence; and to identify possible risk factors for recurrence. ( DATA SOURCE: MEDLINE and EMBASE databases, reference lists of selected articles and authors' libraries.) Nineteen studies were identified. Mortality rate during peri-hospitalization period is 5.6% (range, 0%-15.2%) and 9.4% (range, 0%-39%) at the end of follow-up period. Eighty-eight percent of surviving patients recover completely or have only a mild functional or cognitive deficit. Two thirds of patients with CVT recanalized within the first few months after presentation, and 2.8% (range, 0%-11.7%) had objectively confirmed recurrence. We conclude that patients with CVT have a low risk of death and that most patients have a good long-term prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16609071     DOI: 10.1182/blood-2005-12-4795

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Cerebral venous thrombosis and the risk of pregnancy-related recurrent venous thromboembolism.

Authors:  Valerio De Stefano; Tommaso Za; Elena Rossi
Journal:  Intern Emerg Med       Date:  2010-06-08       Impact factor: 3.397

2.  Cerebral venous sinus thrombosis after allogeneic stem cell transplantation.

Authors:  Kenji Motohashi; Maki Hagihara; Satomi Ito; Takayoshi Tachibana; Hirotaka Takasaki; Masatsugu Tanaka; Atsuo Maruta; Yoshiaki Ishigatsubo; Heiwa Kanamori
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

3.  Efficacy of thromboprophylaxis during pregnancy in women with a previous cerebral vein thrombosis.

Authors:  Francesco Dentali; Nicola Mumoli; Marco Cei
Journal:  Intern Emerg Med       Date:  2017-07-20       Impact factor: 3.397

Review 4.  Cerebral sinus-venous thrombosis.

Authors:  Ida Martinelli; Serena Maria Passamonti; Elena Rossi; Valerio De Stefano
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

5.  Intracranial hemorrhage and extensive cerebral venous thrombosis associated with ulcerative colitis.

Authors:  Muhammad Adrish; Ryan Rios
Journal:  Can J Gastroenterol Hepatol       Date:  2014-06

Review 6.  Managing unusual presentations of venous thromboembolism.

Authors:  Walter Ageno
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

7.  Clinical presentation and long-term outcome of cerebral venous thrombosis.

Authors:  Joey D English; Jeremy D Fields; Scheherazade Le; Vineeta Singh
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

8.  A case of delayed emergence from anesthesia caused by postoperative brain edema associated with unexpected cerebral venous sinus thrombosis.

Authors:  Yuko Kozasa; Hikari Takaseya; Yukari Koga; Teruyuki Hiraki; Yasunori Mishima; Shuhei Niiyama; Kazuo Ushijima
Journal:  J Anesth       Date:  2013-03-23       Impact factor: 2.078

9.  Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies.

Authors:  N Yesilot; S Bahar; S Yilmazer; M Mutlu; M Kurtuncu; R Tuncay; O Coban; G Akman-Demir
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

Review 10.  Cerebral vein thrombosis.

Authors:  Francesco Dentali; Walter Ageno
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.